Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX
作者
Brad R. Woodie,Justin A Freking,Gabrielle M. Rivin,Alan B. Fleischer